首页 | 本学科首页   官方微博 | 高级检索  
     


Neurolupus (1 partie). Description et démarche diagnostique et thérapeutique dans les manifestations neurologiques centrales et psychiatriques au cours du lupus érythémateux systémique
Authors:G. Lefè  vre,H. Zé  phir,F. Warembourg,E. Michelin,J.-P. Pruvo,E. Hachulla,F. Semah,S. Dubucquoi,P. Lenfant,P. Vermersch,P.-Y. Hatron,L. Prin,D. Launay
Affiliation:1. Service de médecine interne, université de Lille Nord-de-France, centre de référence maladies auto-immunes rares (sclérodermie), hôpital Claude-Huriez, CHRU de Lille, 1, rue Michel-Polonovski, 59037 Lille, France;2. EA2686, Institut d’immunologie, université Lille Nord-de-France, faculté de médecine H.-Warembourg, 59037 Lille, France;3. Service de neurologie D, université Lille Nord-de-France, hôpital Roger-Salengro, CHRU de Lille, 59037 Lille, France;4. Service de psychiatrie, consultation de psychiatrie de liaison, université Lille Nord-de-France, hôpital Michel-Fontan, CHRU de Lille, 59037 Lille, France;5. Service de neuroradiologie, hôpital Roger-Salengro, université Lille Nord-de-France, CHRU de Lille, 59037 Lille, France;6. Service de médecine nucléaire et imagerie fonctionnelle, université Lille Nord-de-France, hôpital Roger-Salengro, CHRU de Lille, 59037 Lille, France
Abstract:Systemic lupus erythematosus (SLE) is an autoimmune disease, which primarily affects skin and joints. Peripheral neurologic syndrome and central nervous system (CNS) manifestations are common in lupus patients but are not always attributable to lupus itself. A classification, published in 1999 by the American College of Rheumatology (ACR) research committee, described 12 CNS syndromes and seven peripheral neurologic syndromes compatible with “neuropsychiatric systemic lupus erythematosus” (NPSLE). Despite this consensus, studies which have been published since 1999 have reported a prevalence of NPSLE varying from 20 to 97 %, which shows the diagnosis difficulty and the heterogeneity of neuropsychiatric manifestations in SLE. In order to understand the limits of this classification, we propose in this first part an exhaustive review of publications describing neuropsychiatric manifestations according to the ACR 1999 classification. We also detail case definitions, prevalence and risk factors, clinical characteristics and diagnosis of each lupus-related psychiatric and CNS manifestation.
Keywords:Lupus é  rythé  mateux systé  mique   Neurolupus   Antiphospholipides
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号